FindTrial
Sign In

A comparision between 2 pain killer drugs in endoscopic surgery

A Comparison between Propofol infusion with Fentanyl and Propofol infusion with Nalbuphine for sedation and analgesia for the patient undergoing UGI scopies and associated procedures - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090856
Enrollment
46
Registered
2025-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Injection Propofol 0.15 mg/kg/min IV infusion till procedure ends: sedation and analgesia, sedation will be given till procedure ends Control Intervention1: Injection Fentanyl 2mcg/kg I

Sponsors

Shree Krishna Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients ASA(American society of Anaesthesia)ASA I to ASA III patients undergoing above mentioned UGI scopies

Exclusion criteria

Exclusion criteria: Patient with known allergy to drug to be injected Patient with uncontrolled hypertension Patient with pregnancy Central nervous system abnormality Patient with high cardiac risk Patient with pulmonary disease Patient with any psychiatric illness

Design outcomes

Primary

MeasureTime frame
To compare patient movement score and endoscopist sedation score for sedation and recoveryTimepoint: To compare patient movement score and endoscopist satisfaction score for sedation and recovery during procedure—

Secondary

MeasureTime frame
Acceleration or extra bolus dose of propofol needed,effect on hemodynamics,any episode of desaturation, vas scoreTimepoint: During procedure—

Countries

India

Contacts

Public ContactVaibhavi Hajariwala

Shree krishna hospital, karamsad ,Bhaikaka University

vaibhavih@charutarhealth.org9409206121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026